{"acquisitions":[],"changes":[{"companyHref":"/c/anagramtx-com","date":"2026-10-17","documentUrl":"https://www.wikidata.org/wiki/Q137204456","domain":"anagramtx.com","fact":"provenance:existence","name":"Anagram Therapeutics","new":{"publisher":"Wikidata","status":"sourced","url":"https://www.wikidata.org/wiki/Q137204456"},"old":{"publisher":"anagramtx.com","status":"self-reported","url":"https://anagramtx.com"},"publisher":"Wikidata","reason":null,"retrievedAt":"2026-10-17","slug":"anagramtx-com","status":"sourced","url":"https://whoraisedwhat.com/c/anagramtx-com"}],"country":"US","description":"Anagram Therapeutics develops oral enzyme replacement therapies for rare malabsorption and nutrient metabolism disorders. Its lead candidate ANG003 is in Phase 2 trials for cystic fibrosis and exocrine pancreatic insufficiency in infants, children, and adults. Proprietary enzyme stabilization technology extends activity through the GI tract where competitors degrade.","domain":"anagramtx.com","employees":null,"founded":2017,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":42.283639,"lng":-71.346996,"location":"Natick, MA","multiples":[],"name":"Anagram Therapeutics","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":250000000,"connectionsAmong":[],"currency":"USD","date":"2026-05-08","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"anagramtx-com-2026-05-08-series-c","source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-14","status":"attributed","url":null},"status":"attributed","type":"series-c","url":null}],"slug":"anagramtx-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-14","status":"attributed","url":null},{"fact":"existence","publisher":"Wikidata","retrievedAt":"2026-10-17","status":"sourced","url":"https://www.wikidata.org/wiki/Q137204456"},{"fact":"description","publisher":"anagramtx.com","retrievedAt":"2026-05-14","status":"self-reported","url":"https://anagramtx.com"}],"stage":"series-b+","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["Nginx","Bootstrap 5.3.2","Google Analytics","Google Tag Manager","jQuery CDN","jsDelivr","ExpressionEngine","DoubleClick Floodlight","CodeIgniter","WordPress","PHP","MySQL"],"totalRaisedUsd":285000000,"traction":[],"updatedAt":"2026-05-14","valuations":[]}